LRRC59 and neoplasm: Finally, T cell-mediated tumor cell-killing assay was performed to detected the role of LRRC59 in attenuating the efficacy of immunotherapy, the results showed that LRRC59 knockdown enhances the efficacy of immunotherapy strongly (Figure 10D–10G).